BeyondSpring (BYSI) Current Taxes (2018 - 2026)
BeyondSpring (BYSI) posted Current Taxes of $6000.0 for Q1 2026, down 97.58% sequentially from $248000.0 in Q4 2025, and up 500.0% YoY from $1000.0 in Q1 2025.
BeyondSpring (BYSI) Current Taxes (2018 - 2026) Analysis & Trends
BeyondSpring has reported Current Taxes for 9 years, with the latest figure at $6000.0 in Q1 2026.
- Quarterly Current Taxes rose 500.0% year-over-year to $6000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6000.0 (up 500.0% YoY) and the FY2025 annual result came in at $248000.0, up 24700.0% from the prior year.
- Current Taxes eased to $6000.0 in Q1 2026 per BYSI's latest filing, from $248000.0 in the prior quarter.
- Over five years, Current Taxes peaked at $248000.0 in Q4 2025 and troughed at $1000.0 in Q4 2024.
- A 5-year average of $44000.0 and a median of $6000.0 in 2026 frame the typical range for Current Taxes.
- The sharpest annual moves came in 2022 and 2025: Current Taxes plunged 99.1% in 2022, then jumped 24700.0% in 2025.
- Over 5 years, Current Taxes stood at $32000.0 in 2022, then sank by 43.75% to $18000.0 in 2023, then sank by 94.44% to $1000.0 in 2024, then surged by 24700.0% to $248000.0 in 2025, then sank by 97.58% to $6000.0 in 2026.
- According to Business Quant data, Current Taxes over the past three periods registered $6000.0, $248000.0, and $2000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.88 Bn | 132.03 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.62 Bn | 78.62 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.28 Bn | 60.10 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 61.39 Bn | 56.25 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 31.37 Bn | 28.06 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.76 Bn | 10.37 Bn | 668.28 Mn | 76.36 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | - |
| 10 | BeyondSpring | 30.17 Mn | 30.17 Mn | - | 6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6,000.00 |
| Mar 31, 2026 | 6,000.00 |
| Dec 31, 2025 | 248,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 18,000.00 |
| Dec 31, 2022 | 32,000.00 |
| Dec 31, 2021 | 3.57 Mn |
| Sep 30, 2021 | 2.59 Mn |
| Jun 30, 2021 | 915,000.00 |
| Mar 31, 2021 | 876,000.00 |
| Dec 31, 2020 | 857,000.00 |
| Sep 30, 2020 | 836,000.00 |
| Jun 30, 2020 | 815,000.00 |
| Mar 31, 2020 | 810,000.00 |
| Dec 31, 2019 | 798,000.00 |
| Dec 31, 2018 | 778,000.00 |